Abstract
Aim
The administration of bleomycin plus etoposide and cisplatin during pregnancy is rare.
Materials and methods
We describe a case with good pregnancy outcome after exposure to these chemotherapeutic agents at the third trimester of pregnancy.
Results and discussion
A pregnant woman with stage IIIc immature teratoma underwent surgical staging, and received two cycles of bleomycin, etoposide and cisplatin from the 29th week of pregnancy until delivery. The patient did not have any evidence of recurrence of ovarian cancer for 1.5 years. Her infant did not have any evidence of minor or major malformations, and showed normal neurological development during 1.5 years of follow-up.
Similar content being viewed by others
References
Modares Gilani M, Karimi Zarchi M, Behtash N, Ghaemmaghami F, Mousavi A, Behnamfar F (2007) Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer Apr 12 [Epub ahead of print]
Oduncu FS, Kimming R, Hepp H, Emmerich B (2003) Cancer in pregnancy: maternal-fetal conflict. J Cancer Res Clin Oncol 129:133–146
Jung-Yeol Han, Alejandro A. Nava-Ocampo, Tae-Jin Kim, Jae-Uk Shim, Chong-Taik Park (2005) Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol 19(4):557–561
Greshenson DM, Morris M, Cangir A (1990) Treatment of malignant germ cell tumors. Of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 8:715–720
Horbelt D, Delmore J, Meisel R (1994) Mixed germ cell malignancy of the ovary concurrent with pregnancy. Obstet Gynecol 84:662–664
Elit L, Bocking A, Kenyon C (1999) An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 72:123–127
Segelov E, Campbell J, Ng M, Tatters all M (1994) Cisplatin based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12:378–384
Williams S, Blessing JA, Liao SY, Ball H, Hanjani P (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the gynecologic oncology group. J Clin Oncol 12:701–706
Tewari K, Cappuccini F, Disaia PJ (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95:128–133
Takahashi N, Kai S, Kohmura H, Ishikawa K, Kuroyanagi K, Hamajima Y, et al (1986) Reproduction studies of VP 16–213. Part I: oral administration to rats prior to and in the early stages of pregnancy (in Japanese). J Toxicol Sci 11:(Suppl. 1) 177–194
Raffles A, Williams J, Costeloe K, Clark P (1989) Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynecol 96:1099–1100
Avelis A, Diaz- Maqueo JC, Talavera A (1991) Growth and development of children of mothers treated with chemotherapy during pregnancy: curent status of 43 children. Am J Hematol 36:243–248
Segna RA, Mitchell DR, Misas JE (1990) Successful treatment of cervical pregnancy with oral etoposide. Obstet Gynecol 76:945–947
Kusaka M, Tanaka T, Fujimoto S (1994) Local etoposide injection for treatment of tubal pregnancy with cardiac activity. Int J Fertil Menopausal Stud 39:11–13
Mariana Gerschenson, Catherine Y. Paik, Emily L. Gaukler, Bhalchandra A. Diwan, Miriam C. Poirier (2001) Cisplatin exposure induces mitochondrial toxicity in pregnant rats and their fetuses. Reprod Toxicol 15(5):525–531
Ghaemmaghami F, Hasanzadeh M (2006) Good fetal outcome of pregnancies with gynecologic cancer conditions: cases and literature review. Int J Gynecol Cancer 16(1):1–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karimi Zarchi, M., Behtash, N. & Modares Gilani, M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet 277, 75–78 (2008). https://doi.org/10.1007/s00404-007-0416-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0416-3